US Stock MarketDetailed Quotes

VTVT vTv Therapeutics

Watchlist
  • 13.9700
  • +0.7700+5.83%
Close Dec 30 16:00 ET
36.49MMarket Cap-3.20P/E (TTM)

vTv Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-32.77%-6.42M
-9.11%-6.73M
-41.99%-7.34M
-19.09%-19.08M
57.65%-2.91M
45.24%-4.83M
-973.51%-6.17M
-405.97%-5.17M
17.02%-16.02M
-7.22%-6.88M
Net income from continuing operations
31.62%-5.84M
11.12%-6.41M
-4.24%-6.02M
-3.56%-25.97M
27.08%-4.44M
-56.18%-8.54M
-76.26%-7.21M
38.73%-5.77M
-41.41%-25.07M
35.78%-6.09M
Operating gains losses
52.49%-162K
36.30%-193K
55.88%371K
-284.25%-3.64M
-345.38%-3.23M
-205.25%-341K
-471.70%-303K
148.37%238K
41.21%-946K
27.35%-725K
Depreciation and amortization
0.00%22K
0.00%23K
0.00%22K
-2.17%90K
0.00%23K
-8.33%22K
4.55%23K
-4.35%22K
3.37%92K
4.55%23K
Other non cash items
----
----
----
163.20%213K
--0
--0
--0
--213K
---337K
---146K
Change In working capital
-2,589.58%-1.29M
-180.08%-1.01M
-201.74%-1.93M
-18.40%4.39M
256.83%1.29M
98.63%-48K
-72.27%1.26M
-63.27%1.9M
15,285.71%5.39M
-122.27%-820K
-Change in receivables
--64K
--675K
-608.09%-879K
161.21%71K
12.07%-102K
--0
--0
--173K
-214.85%-116K
-113.32%-116K
-Change in prepaid assets
-41.79%-777K
-48.66%268K
-31.55%473K
458.06%1.44M
161.94%778K
3.52%-548K
-24.24%522K
-5.60%691K
51.97%-403K
-166.10%-1.26M
-Change in payables and accrued expense
-213.00%-565K
-362.87%-1.94M
-246.41%-1.51M
442.17%2.93M
17.47%659K
116.93%500K
125.50%738K
-76.70%1.03M
-146.83%-856K
-83.21%561K
-Change in other current assets
--30K
--30K
--28K
--105K
--105K
--0
--0
--0
--0
----
-Change in other current liabilities
---43K
---42K
---40K
---154K
---154K
--0
--0
--0
--0
----
-Change in other working capital
----
----
----
----
----
----
----
----
772.64%6.76M
0.00%-9K
Cash from discontinued investing activities
Operating cash flow
-32.77%-6.42M
-9.11%-6.73M
-41.99%-7.34M
-19.09%-19.08M
57.65%-2.91M
45.24%-4.83M
-973.51%-6.17M
-405.97%-5.17M
17.02%-16.02M
-7.22%-6.88M
Investing cash flow
Cash flow from continuing investing activities
21,071.43%4.4M
-21K
0
Net PPE purchase and sale
----
----
----
--0
----
----
----
----
---21K
--0
Net business purchase and sale
----
----
----
--4.4M
----
----
----
----
--0
----
Cash from discontinued investing activities
Investing cash flow
----
----
----
21,071.43%4.4M
----
----
----
----
---21K
--0
Financing cash flow
Cash flow from continuing financing activities
420.72%2.46M
0
324.73%50.14M
-18.69%12M
-107.69%-282K
-92.50%473K
0
4,711.72%11.81M
-45.31%14.75M
1,278.57%3.67M
Net issuance payments of debt
--0
--0
-101.62%-191K
-3.13%-33K
-3,597.30%-12.31M
-15.08%473K
--0
4,711.72%11.81M
-118.60%-32K
12.37%-333K
Net common stock issuance
--2.46M
--0
--50.34M
-18.64%12.03M
23.44%12.03M
--0
--0
--0
-44.74%14.79M
1,408.67%9.75M
Proceeds from stock option exercised by employees
----
----
----
--0
----
----
----
----
--0
---5.75M
Cash from discontinued financing activities
Financing cash flow
420.72%2.46M
--0
324.73%50.14M
-18.69%12M
-107.69%-282K
-92.50%473K
--0
4,711.72%11.81M
-45.31%14.75M
1,278.57%3.67M
Net cash flow
Beginning cash position
261.35%45.53M
178.46%52.26M
-22.10%9.45M
-9.61%12.13M
-46.29%8.24M
-29.47%12.6M
54.61%18.77M
-9.61%12.13M
133.43%13.42M
-21.60%15.34M
Current changes in cash
9.31%-3.96M
-9.11%-6.73M
544.71%42.81M
-107.91%-2.68M
137.60%1.21M
-72.78%-4.36M
-207.72%-6.17M
619.97%6.64M
-116.81%-1.29M
47.76%-3.21M
End cash Position
404.62%41.57M
261.35%45.53M
178.46%52.26M
-22.10%9.45M
-22.10%9.45M
-46.29%8.24M
-29.47%12.6M
54.61%18.77M
-9.61%12.13M
-9.61%12.13M
Free cash flow
-32.77%-6.42M
-9.11%-6.73M
-41.99%-7.34M
-18.94%-19.08M
57.65%-2.91M
45.24%-4.83M
-1,000.29%-6.17M
-405.97%-5.17M
16.91%-16.04M
-7.22%-6.88M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -32.77%-6.42M-9.11%-6.73M-41.99%-7.34M-19.09%-19.08M57.65%-2.91M45.24%-4.83M-973.51%-6.17M-405.97%-5.17M17.02%-16.02M-7.22%-6.88M
Net income from continuing operations 31.62%-5.84M11.12%-6.41M-4.24%-6.02M-3.56%-25.97M27.08%-4.44M-56.18%-8.54M-76.26%-7.21M38.73%-5.77M-41.41%-25.07M35.78%-6.09M
Operating gains losses 52.49%-162K36.30%-193K55.88%371K-284.25%-3.64M-345.38%-3.23M-205.25%-341K-471.70%-303K148.37%238K41.21%-946K27.35%-725K
Depreciation and amortization 0.00%22K0.00%23K0.00%22K-2.17%90K0.00%23K-8.33%22K4.55%23K-4.35%22K3.37%92K4.55%23K
Other non cash items ------------163.20%213K--0--0--0--213K---337K---146K
Change In working capital -2,589.58%-1.29M-180.08%-1.01M-201.74%-1.93M-18.40%4.39M256.83%1.29M98.63%-48K-72.27%1.26M-63.27%1.9M15,285.71%5.39M-122.27%-820K
-Change in receivables --64K--675K-608.09%-879K161.21%71K12.07%-102K--0--0--173K-214.85%-116K-113.32%-116K
-Change in prepaid assets -41.79%-777K-48.66%268K-31.55%473K458.06%1.44M161.94%778K3.52%-548K-24.24%522K-5.60%691K51.97%-403K-166.10%-1.26M
-Change in payables and accrued expense -213.00%-565K-362.87%-1.94M-246.41%-1.51M442.17%2.93M17.47%659K116.93%500K125.50%738K-76.70%1.03M-146.83%-856K-83.21%561K
-Change in other current assets --30K--30K--28K--105K--105K--0--0--0--0----
-Change in other current liabilities ---43K---42K---40K---154K---154K--0--0--0--0----
-Change in other working capital --------------------------------772.64%6.76M0.00%-9K
Cash from discontinued investing activities
Operating cash flow -32.77%-6.42M-9.11%-6.73M-41.99%-7.34M-19.09%-19.08M57.65%-2.91M45.24%-4.83M-973.51%-6.17M-405.97%-5.17M17.02%-16.02M-7.22%-6.88M
Investing cash flow
Cash flow from continuing investing activities 21,071.43%4.4M-21K0
Net PPE purchase and sale --------------0-------------------21K--0
Net business purchase and sale --------------4.4M------------------0----
Cash from discontinued investing activities
Investing cash flow ------------21,071.43%4.4M-------------------21K--0
Financing cash flow
Cash flow from continuing financing activities 420.72%2.46M0324.73%50.14M-18.69%12M-107.69%-282K-92.50%473K04,711.72%11.81M-45.31%14.75M1,278.57%3.67M
Net issuance payments of debt --0--0-101.62%-191K-3.13%-33K-3,597.30%-12.31M-15.08%473K--04,711.72%11.81M-118.60%-32K12.37%-333K
Net common stock issuance --2.46M--0--50.34M-18.64%12.03M23.44%12.03M--0--0--0-44.74%14.79M1,408.67%9.75M
Proceeds from stock option exercised by employees --------------0------------------0---5.75M
Cash from discontinued financing activities
Financing cash flow 420.72%2.46M--0324.73%50.14M-18.69%12M-107.69%-282K-92.50%473K--04,711.72%11.81M-45.31%14.75M1,278.57%3.67M
Net cash flow
Beginning cash position 261.35%45.53M178.46%52.26M-22.10%9.45M-9.61%12.13M-46.29%8.24M-29.47%12.6M54.61%18.77M-9.61%12.13M133.43%13.42M-21.60%15.34M
Current changes in cash 9.31%-3.96M-9.11%-6.73M544.71%42.81M-107.91%-2.68M137.60%1.21M-72.78%-4.36M-207.72%-6.17M619.97%6.64M-116.81%-1.29M47.76%-3.21M
End cash Position 404.62%41.57M261.35%45.53M178.46%52.26M-22.10%9.45M-22.10%9.45M-46.29%8.24M-29.47%12.6M54.61%18.77M-9.61%12.13M-9.61%12.13M
Free cash flow -32.77%-6.42M-9.11%-6.73M-41.99%-7.34M-18.94%-19.08M57.65%-2.91M45.24%-4.83M-1,000.29%-6.17M-405.97%-5.17M16.91%-16.04M-7.22%-6.88M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.